Toronto, Ontario — January 12, 2026 — Leads & Copy — Predictmedix AI Inc. has announced its proposed name change to QScreen AI Inc., along with a new ticker symbol, QAI, pending regulatory approval.
The company said the rebranding reflects its transformation into a healthcare innovator focused on artificial intelligence, quantum-inspired computing, and data-driven health solutions.
QScreen AI Inc. aims to enhance preventive screening, diagnostics, and personalized care by leveraging quantum-AI synergies and a large collection of health data, the company said. The goal is to provide accurate, inclusive, and efficient solutions for global healthcare challenges.
According to the company, QScreen AI Inc. stands for “Quantum Screening” and utilizes AI platforms enhanced by quantum-inspired algorithms to process complex health data. These hybrid quantum-classical models use principles of quantum mechanics to improve multispectral signal processing, reduce noise, and mitigate bias.
The company says these techniques enable detailed analysis of vital signs, physiological markers, and imaging data, improving clarity and accuracy across diverse populations and conditions. This technology runs on standard hardware, making it accessible without specialized quantum infrastructure, the company added.
With over 720,000 scans from its SmartHealth AI Stations, QScreen AI has a large dataset that it says is used to refine AI models. These quantum-enhanced predictions are designed to improve with each deployment, allowing for early detection of chronic conditions, mental health assessments, and infectious disease screening.
Dr. Rahul Kushwah, COO of Predictmedix AI Inc., said that the transition to QScreen AI Inc. will allow the company to amplify AI’s potential in healthcare. He added that integrating quantum-inspired techniques with extensive data assets will transform how health and wellness are approached, positioning the company for growth, partnerships, and shareholder returns.
The company is also adding industry experts to help with the global commercialization of its quantum-AI technologies.
Shareholders will be updated on the name change and ticker symbol update process as approvals are granted. Further details on product validations, pilot programs, and partnerships can be found in earlier press releases.
Dr. Rahul Kushwah, COO
rahul@predictmedix.com
(647) 889 6916
Source: Predictmedix AI Inc.
